Nitroglycerine 2.6 mg (Controlled Release) Tablet (Nitrocam-2.6)

Nitroglycerine 2.6 mg (Controlled Release)

Nitrocam-2.6 Tablet — Nitroglycerine 2.6 mg (Controlled Release) from Trumac Healthcare PCD Pharma Franchise India

Composition Nitroglycerine 2.6 mg (Controlled Release)
Dosage Form Tablet
Pack Type Bottle
Pack Size 1 x 30 (Bottle)
MRP ₹ 145
Therapy Cardiac + Diabetic — Nitrate (controlled-release oral)
Storage Store below 25°C, protect from light, in tightly closed container.

WhatsApp EnquiryCall: +919041677932

For chemists, distributors and doctors: Nitrocam-2.6 (nitroglycerine 2.6 mg (controlled release) tablet) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.

WhatsApp for price list & availability

About Nitrocam-2.6 Tablet

Nitrocam-2.6 Tablet contains Nitroglycerine 2.6 mg (Controlled Release). Nitroglycerine in controlled-release form provides sustained nitrate delivery for chronic angina prophylaxis.

Indicated for prophylaxis of chronic stable angina pectoris. Used to reduce frequency and severity of angina attacks.

Camrut Healthcare manufactures the Nitrocam range under WHO-GMP conditions for PCD pharma franchise across India.

Looking up another Trumac medicine? See what every Trumac Healthcare brand is used for – A–Z in English and Hindi: Trumac Healthcare tablet uses. Take medicines only as your doctor prescribes.

Indications

  • Chronic stable angina prophylaxis
  • Vasospastic angina
  • Adjunct in heart failure (rarely used)

Mechanism of Action

Nitroglycerine is converted in vascular smooth muscle to nitric oxide (NO), which activates guanylate cyclase. The resulting cGMP increase causes smooth-muscle relaxation, predominantly venodilation at lower doses (reducing preload) and additional arteriolar dilation at higher doses (reducing afterload). Together these reduce myocardial oxygen demand.

Dosage & Administration

['Adults: 1 tablet 2–3 times daily', 'Allow 8–12 hour nitrate-free interval to prevent tolerance', 'Swallow whole — do not crush or chew', 'Keep in tightly closed original container']

Side Effects

['Headache (very common, dose-related)', 'Postural hypotension', 'Flushing', 'Tachycardia', 'Tolerance with chronic continuous use']

Contraindications & Precautions

['Severe hypotension', 'Concurrent PDE-5 inhibitors (Sildenafil etc)', 'Severe anaemia', 'Raised intracranial pressure', 'Hypertrophic obstructive cardiomyopathy']

Storage

Store below 25°C, protect from light, in tightly closed container.

Part of our PCD pharma franchise range, available on a monopoly basis – see the cardiac diabetic PCD franchise product list. No franchise fee; minimum first order ₹25,000 – cost and documents.

PCD Pharma Franchise & Third-Party Manufacturing
Nitrocam-2.6 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

q

a

q

a

q

a

q

a

q

a

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.